were proved in several experimental focal or global cerebral ischemia models. 3, 10, 18, 21, 22 The aim of the present study was to determine the effects of presynaptic glutamate release inhibition on SCI by evaluating oxidative stress parameters and the ultrastructural integrity of the spinal cord by the use of electron microscopy.
Methods

Animal Preparation
A total of 66 adult female Wistar rats weighing between 250 and 300 g each were used for this study. Prior to surgery, animals were randomly assigned to one of 6 groups, housed 5 to 6 rats per cage, exposed to a 12-hour light/dark cycle, and given free access to food and water. The Animal Ethics and Research Committee of Gazi University approved all protocols.
Surgical Procedure
The surgical procedure was performed after general anesthesia was induced by 50 mg/kg intramuscular xylazine (Rompun, Bayer). Using the prominent spinous process of the T-2 vertebra as the surgical landmark, T3-7 laminectomies were performed through a dorsal incision with the rat placed prone, and an ~ 1-cm-long dural segment was exposed. We used the extradural clip compression model described by Rivlin and Tator 19 to produce experimental SCI. An aneurysm clip (Yașargil, catalog No. 65.250; Peter Lazic) was applied extradurally at a closing force of 90 g for 60 seconds.
Drugs Used in the Experiment
Lamotrigine (3,5-diamino-6-[2,3-dichlorophenyl]-1,2,4-triazine) was a gift from GlaxoSmithKline Foundation. Pure lamotrigine is insoluble in water; thus it was dissolved in DMSO for a final concentration of 30 mg/ml. The same amount of DMSO used for treatment groups was also administered to the vehicle group to determine the effects of this solvent on the experimental animals. The solutions were administered to treatment groups by slow intraperitoneal injection.
Experimental Groups
The animals were randomly allocated into 6 groups of 11 rats each, as follows. Group I (control group): laminectomies were performed, but medication was not administered, nor was SCI induced in the rats. The spinal cord and blood samples were used to obtain the basal values. Group II (trauma group): SCI was performed, but no medication was administered to the rats. Group III (vehicle group): an equal amount of DMSO to that used as solvent for treatment groups was administered to the rats. Group IV (pretreatment group): 50 mg/kg lamotrigine was administered intraperitoneally to the rats 30 minutes before experimental SCI. Group V (peritreatment group): 50 mg/kg lamotrigine was administered intraperitoneally to the rats simultaneously with experimental SCI. Group VI (posttreatment group): 50 mg/kg lamotrigine was administered intraperitoneally to the rats 30 minutes after experimental SCI.
Sample Preparation
The oxidative stress parameters reach peak concentration over 1-5 hours after SCI and decrease gradually. Seven rats in each group were killed with a lethal dose of intraperitoneal pentobarbital sodium 2 hours post injury for the biochemical analysis. The remaining 4 rats in each group were killed in the same fashion 24 hours postinjury, and the spinal cord tissue samples were collected for pathological analysis. One centimeter of the injured spinal cord segment was removed, weighed, and immediately frozen and stored at -70°C until analysis for tissue MDA was performed. Subsequently, 2-ml blood samples were drawn into tubes containing heparin; these were separated into 0.5-ml whole blood samples for GPX analysis, washed erythrocyte samples for SOD analysis, and plasma samples for MDA analysis.
Biochemical Analysis
Tissue MDA Analysis. The relative levels of tissue MDA, an indicator of lipid peroxidation, were measured using a thiobarbituric acid assay as described by Ohkawa et al. 15 The levels of tissue MDA were expressed as "nmol/g wet tissue." Plasma MDA Analysis. Plasma lipid peroxide levels were measured colorimetrically by the thiobarbituric acid assay described by Yoshioka et al., 23 and expressed as "nmol/ml."
Erythrocyte SOD Activity Analysis. Addition of SOD accelerates the dismutation of the toxic superoxide radicals (O 2 -) produced during the oxidative energy process into H 2 O 2 and molecular O 2 . The SOD levels are decreased by excessive oxidative stress. We measured the erythrocyte SOD activity with the aid of a RANSOD Kit (SD125, Randox). The Hb levels were measured using the Drabkin method, 5 and results were expressed as "U/g Hb."
Glutathione Peroxidase Activity Analysis. The GPX activity of blood was measured according to the method described by Paglia and Valentine, 16 by using a RANSEL Kit (RS504, Randox). The Hb levels were measured using the Drabkin method, and results were expressed as "U/g Hb". 5 Pathological Analysis. The 4 spinal cord samples used for pathological analysis were collected 24 hours after experimental injury, because the expected histopathological changes become evident over 24 hours. A 1-cm spinal cord segment was removed from each injury site, and divided from the epicenter of the contusion level.
Transmission Electron Microscopy Analysis
The tissues used for transmission electron microcopy were kept in 2.5% glutaraldehyde and 2% paraformaldehyde solutions for 24 hours, postfixed with phosphatebuffered 2% OsO 4 for 1 hour, and dehydrated in a graded series of alcohols. The samples were embedded in aralde-hyde, then 1-to 2-micron semithin sections were obtained with an ultratome (Reichert Supernova) and stained with toluidine blue. Semithin sections were evaluated under a light microscope (Olympus CH-2), and characteristic areas were chosen as sites for thin sections. The thin sections were obtained with the same ultratome, uranyl acetate and lead citrate were added as contrast agents, and sections were evaluated with the transmission electron microscope (EM 900, Carl Zeiss, Inc.). An ultrastructural scoring system described by Kaptanoglu and colleagues 8, 9 was used for quantitative evaluation of the spinal cord samples (Table 1) . Twenty neurons/sample were evaluated for intracellular edema and nucleus; 20 axons/sample were evaluated for axonal changes; and 20 mitochondria/sample were evaluated for mitochondrial changes.
Statistical Analysis
All the data collected throughout the experiment were analyzed using SPSS for Windows version 10.0 statistical software. Statistical analysis of each parameter was performed using one-way analysis of variance. The Tukey test was applied for intergroup comparisons and a probability value less than 0.05 was accepted as statistically significant.
Results
Tissue MDA Levels
The mean tissue MDA levels were 25.83 nmol/g for the control group, 46.94 nmol/g for the trauma group, 45.71 nmol/g for the vehicle group, 29.71 nmol/g for the pretreatment group, 29.45 nmol/g for the peritreatment group, and 41.2 nmol/g for the posttreatment group. There was a statistically significant difference between control and trauma groups (p < 0.05). The vehicle group did not show a difference from the trauma group (p > 0.05). This result showed that the solvent did not change the oxidative stress parameters at the dose used. There were statistically significant differences between the trauma group and pre-and peritreatment groups (p < 0.05). Nevertheless, there was no statistically significant difference between the trauma and posttreatment groups (p > 0.05) (Fig. 1) .
Plasma MDA Levels
The mean plasma MDA levels were 10.16 nmol/ ml for the control group, 21.05 nmol/ml for the trauma group, 20.57 nmol/ml for the vehicle group, 10.96 nmol/ ml for the pretreatment group, 10.75 nmol/ml for the peritreatment group, and 10.59 nmol/ml for the posttreatment group. There was a statistically significant difference between the control and trauma groups (p < 0.05). The vehicle group did not differ significantly from the trauma group (p > 0.05). Plasma MDA levels in the trauma group were significantly higher than in pre-, peri-, and posttreatment groups (p < 0.05). There were no statistically significant differences between the treatment groups (p > 0.05) (Fig. 2) .
Erythrocyte SOD Activity
The mean plasma SOD activity levels were 4083 U/g Hb for the control group, 1874 U/g Hb for the trauma group, 1793 U/g Hb for the vehicle group, 3830 U/g Hb for the pretreatment group, 3574 U/g Hb for the peritreatment group, and 2713 U/g Hb for the posttreatment group. There was a statistically significant difference between the control and trauma groups (p < 0.05). The difference between the vehicle and trauma groups was not significant (p > 0.05). Erythrocyte SOD activities in pre-and * Twenty neurons/sample were evaluated for intracellular edema and nucleus, 20 axons/sample were evaluated for axonal changes, and 20 mitochondria/sample were evaluated for mitochondrial changes. peritreatment groups were significantly higher than the trauma group (p < 0.05), but there was no statistically significant difference between the trauma group and the posttreatment group (p > 0.05) (Fig. 3) .
Plasma GPX Activity
The mean plasma GPX activity levels were 17.59 U/g Hb for the control group, 12.51 U/g Hb for the trauma group, 11.43 U/g Hb for the vehicle group, 16.66 U/g Hb for the pretreatment group, 17.56 U/g Hb for the peritreatment group, and 14.13 U/g Hb for the posttreatment group. A statistically significant difference was found between the control and trauma groups (p < 0.05). The vehicle group did not show a difference from the trauma group (p > 0.05). The GPX activities in the pretreatment group were significantly higher than in the trauma group (p < 0.05), but we did not find statistically significant differences between the trauma group and the peri-and posttreatment groups (p > 0.05) (Fig. 4) .
Lamotrigine (50 mg/kg) treatment appeared to be neuroprotective from oxidative stress when it was applied before or during, but not after the SCI.
Electron Microscopic Evaluation Results
The control group demonstrated normal spinal cord ultrastructure, whereas the trauma group showed significant damage to the ultrastructure. Severe intracytoplasmic and mitochondrial edema, damage to the neuronal nuclei, cracked or completely destroyed myelin layers, and few axons in the white matter were seen in the trauma group. The vehicle group demonstrated similar findings to the trauma group. The ultrastructure of the spinal cord was significantly spared in all treatment groups. Mostly, preserved axons, intact myelin layers, normal nuclei, and mitochondria were seen in the treatment groups (Figs. 5 and 6 ).
According to the ultrastructural grading system described by Kaptanoglu and colleagues, 8, 9 there were statistically significant differences between the control group and the trauma and vehicle groups (p < 0.05). The vehicle group did not show a significant difference from the trauma group (p > 0.05). The pre-, peri-, and posttreatment groups showed significant ultrastructural protection compared with the trauma group (p < 0.05). There were no statistically significant differences between the treatment groups (p > 0.05).
Discussion
Following SCI, glutamate concentration reaches toxic levels.
12,17 Liu et al. reported that SCI causes a dramatic and long-lasting increase of excitatory amino acids, probably high enough to kill neurons. Glutamate shows its excitotoxic effects through well-known glutamate receptors such as NMDA, AMPA, KA, and mGluRs. 1, 2, 4, 11, 14, 22 Studies have shown that glutamate exacerbates different processes of neuronal injury. First, it promotes an intracellular Ca ++ increase, which may activate proteolysis and lipid peroxidation, damaging the cellular membrane and resulting in neuronal death. Second, glutamate mediates significant ion shifts that cause cellular edema. 1, 2, 4, 11, 12, 14, 17, 22 It becomes evident from these earlier studies that the glutamate-activated process is the keystone in traumatic neuronal injury, and that pharmacological interventions at different steps of the excitotoxic cascade may help attenuate traumatic neuronal death. That is why so many glutamate receptor antagonists were used in experimental SCI. Overstimulation of NMDA receptors by a high concentration of glutamate causes Ca ++ influx and mediates neuronal Ca ++ -related cytotoxicity. Beneficial effects of some NMDA receptor antagonists such as MK-801 were reported in different central nervous system trauma and ischemia models. 1, 4, 11 However, adverse effects such as cognitive dysfunction and the hallucinogenic properties of MK-801 restricted its clinical use.
13
It is now clear that other ionotropic receptors, such as AMPA and KA, are directly permeable to Ca ++ in addition to their Na + permeability. 1, 6, 13, 22 Because they can be important sources of Ca ++ influx in neurons, some AMPA/KA receptor blockers such as NBQX were used in experimental SCI models, and beneficial effects were reported. 6, 13 Nephrotoxic adverse effects of NBQX limited its clinical usage.
The other glutamate receptors are nonionotropic receptors, known as mGluRs. Among these receptors, Group I mGluR activation initiates a number of intracellular pathways that lead to further transmitter release. 2, 14 Group II and III mGluRs regulate neurotransmitters in pathological states such as trauma and ischemia. 2, 14 The effects of mGluR antagonists on experimental SCI were investigated in some recent studies. Results suggested that mGluRs play important roles in excitotoxicity after spinal trauma and development of chronic central pain syndromes. 2, 14 All these data demonstrated that glutamate shows its excitotoxic effect through several different receptor types. Currently, no available agent has been identified that can block all the glutamate receptors at the same time. To prevent excitotoxicity in SCI, inhibiting glutamate release from the presynaptic buttons instead of blocking the postsynaptic glutamate receptors seems to be a more rational method.
Lamotrigine is an antiepileptic drug that inhibits presynaptic glutamate release through voltage-gated Na + channel blockage. Neuroprotective effects of lamotrigine have been reported in several experimental models. Lamotrigine reduces infarct volume and lipid peroxidation and improves neurological outcome after focal and global cerebral ischemia. 3, 18, 20, 21 The most important neuroprotective action of lamotrigine is inhibition of overstimulation of glutamate receptors by decreasing presynaptic glutamate release in pathological states. Moreover, cell culture studies demonstrated that lamotrigine has direct antagonistic effects on Ca channels in addition to Na + channels. 10, 21 Because lamotrigine inhibits Na + influx through voltage-gated Na + channel blockage, it may diminish the accumulation of intracellular Na + and the movement of water into the neurons. Also it may maintain more stable and more negative membrane potentials. 10, 21 The aim of this study was to determine the effects of inhibition of presynaptic glutamate release by lamotrigine on experimental SCI. We administered 50 mg/ kg lamotrigine intraperitoneally to the treatment groups 30 minutes before, 30 minutes after, and simultaneously with the SCI. Neuroprotective effects of 50 mg/kg lamotrigine have been shown in previous studies, with no significant adverse effects reported. Rataud et al. 18 reported that animals treated with 50 mg/kg but not 25 mg/ kg lamotrigine showed significant reduction in the size of cortex infarction in focal cerebral ischemia. In the study by Bacher and Zornow, 3 the authors reported that, in a transient global cerebral ischemia model, 50 mg/kg lamotrigine was more effective in inhibiting the glutamate accumulation than 20 mg/kg lamotrigine.
Because pure lamotrigine is insoluble in water, we dissolved it in DMSO, with a final concentration of 30 mg lamotrigine/1 ml DMSO. Some beneficial effects of DMSO on SCI have been reported in previous studies. 24 Nevertheless, the dose of DMSO used as the solvent in the present study was approximately one-tenth of its therapeutic dose. 24 We administered the same amount of DMSO to the vehicle group to evaluate the potential effects of the solvent in our study. There were no statistically significant differences in any oxidative stress parameters and results of histopathological analysis between the trauma and vehicle groups.
In our study, the effects of presynaptic glutamate release inhibition by lamotrigine on oxidative stress were evaluated by assessing plasma and tissue MDA, SOD, and GPX levels. The results suggested that lamotrigine diminishes the level of oxidative stress parameters in SCI, but only when it was applied before or simultaneously with the injury. However, beneficial effects on oxidative stress were not observed when lamotrigine was applied 30 minutes after the SCI. Because glutamate reaches a peak level within 15-30 minutes after SCI, the treatment administered after that period may be ineffective in preventing excitotoxic events. 12, 17 Histopathological changes in the present study were evaluated by electron microscopic analysis. Presynaptic glutamate release inhibition was highly protective to the spinal cord ultrastructure after SCI in pre-, peri-, and posttreatment groups.
Although presynaptic glutamate release inhibition by lamotrigine treatment 30 minutes after SCI was not effective on oxidative stress parameters (except blood MDA levels), highly protective effects have been shown on the spinal cord ultrastructure. In our opinion, these effects can be related to different neuroprotective mechanisms of lamotrigine such as its membrane stabilizing and antiedema effects, in addition to its well-known role as an antiexcitotoxic. Limitations of this work are the brief posttreatment period and absence of neurobehavioral assessments.
Conclusions
By exhibiting protective effects on the spinal cord ultrastructure even after SCI, presynaptic glutamate release inhibitors such as lamotrigine are promising drugs in the treatment of these injuries. To the best of our knowledge, this is the first study on the neuroprotective effects of presynaptic glutamate release. Further research, such as neurobehavioral assessment, is warranted to explore whether the beneficial effects of presynaptic glutamate release inhibition on the spinal cord ultrastructure will have any beneficial functional implications in the long term.
